WAY-169916

CAS No. 669764-18-5

WAY-169916( —— )

Catalog No. M24682 CAS No. 669764-18-5

WAY-169916 is a pathway-selective inhibitor of estrogen receptor (ER).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 87 In Stock
10MG 147 In Stock
25MG 312 In Stock
50MG 520 In Stock
100MG 750 In Stock
500MG 1521 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    WAY-169916
  • Note
    Research use only, not for human use.
  • Brief Description
    WAY-169916 is a pathway-selective inhibitor of estrogen receptor (ER).
  • Description
    WAY-169916 is a pathway-selective inhibitor of estrogen receptor (ER). It acts by inhibiting NF-kB transcriptional activity but being devoid of conventional estrogenic activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    NF-κB
  • Recptor
    NF-κB
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    669764-18-5
  • Formula Weight
    334.29
  • Molecular Formula
    C17H13F3N2O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:Soluble
  • SMILES
    C=CCn(c1c(C(F)(F)F)cccc11)nc1-c(ccc(O)c1)c1O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Liu Z, et al. Synthesis of 1H-indazoles from N-tosylhydrazones and nitroaromatic compounds. Chem Commun (Camb). 2014 May 21;50(39):5061-3.
molnova catalog
related products
  • Grape Seed Extract

    Grape Seed Extract is exudate from seeds of the grape plant Vitis vinifera, composed of oils and secondary plant metabolites (bioflavonoids and polyphenols) credited with important medicinal properties.

  • Asatone

    Asatone, an active component isolated from Radix et Rhizoma Asari, has an anti-inflammatory effect via activation of NF-κB and downregulation of p-MAPK (ERK, JNK, and p38) pathways.

  • NF-κB/MAPK-IN-1

    NF-κB/MAPK-IN-1 is a potent dual inhibitor of the NF-κB and MAPK pathways with potential anti-inflammatory activity, inhibition of NO production, and inhibition of LPS-induced activation of iNOS, COX-2, ERΚ and P38.